Rescuing its expression in osteosarcoma cells resulted in downregulation of N-cadherin and vimentin and upregulation of E-cadherin, which indicates that FHIT controls the switch between mesenchymal and epithelial markers [67]. The gene discussed is CDH2; the disease is osteosarcoma.